Last reviewed · How we verify
NCT05145530
Selective Nerve Root Block With Ultrasound Guidance Improves Surgical Outcome of Selective Discectomy in Patients With Multilevel Cervical Disc Disease
Phase 2, PHASE3 trial testing selective anterior cervical discectomy and fusion (ACDF) in Selective Nerve Root Block in 60 participants. Completed in 30 April 2020.
30 March 2020
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 60 |
| Start date | 10 August 2017 |
| Primary completion | 30 March 2020 |
| Estimated completion | 30 April 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- selective anterior cervical discectomy and fusion (ACDF)
- SNRB+ selective anterior cervical discectomy and fusion (ACDF)
Conditions studied
- Selective Nerve Root Block — all drugs for Selective Nerve Root Block →
- Selective Discectomy — all drugs for Selective Discectomy →
Sponsor
Assiut University
Who can join
Adults 30 to 60, any sex, with Selective Nerve Root Block or Selective Discectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Disc degeneration is a natural part of growing older. Up to 60% of asymptomatic people have MRI findings that are positive. As a result, MRI only provides morphological information and may not be able to determine the clinical significance of the findings.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ultrasound-Guided Selective Nerve Root Block for Surgical Planning in Multilevel Cervical Disc Disease: A Technical Report.
Lam KHS, Yoon Y, Su DC, Suhaimi A, et al · · 2026 · PMID 42028518 · DOI 10.7759/cureus.105690
Verify or expand the search:
- PubMed search for NCT05145530
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05145530 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 4 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05145530.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing